Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OREX

Orexigen Therapeutics (OREX) Stock Price, News & Analysis

Orexigen Therapeutics logo

About Orexigen Therapeutics Stock (NASDAQ:OREX)

Advanced Chart

Key Stats

Today's Range
$0.22
$0.32
50-Day Range
$0.22
$0.22
52-Week Range
$0.17
$3.81
Volume
3.74 million shs
Average Volume
1.16 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OREX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orexigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OREX Stock News Headlines

Orexigen Therapeutics Stock Price History
I’d rather trade news like this than gamble on hype
Real traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal just triggered a key alert in Tim Sykes’ system… and the setup looks strong.
Xeno Biosciences Announces New CEO and Financing
Orexigen Tanks After-Hours on Obesity Data
See More Headlines

OREX Stock Analysis - Frequently Asked Questions

Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced its quarterly earnings results on Monday, November, 13th. The biopharmaceutical company reported ($1.35) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.13) by $0.78. The firm's quarterly revenue was up 170.0% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Orexigen Therapeutics investors own include Lexicon Pharmaceuticals (LXRX), Arena Pharmaceuticals (ARNA), MannKind (MNKD), Novavax (NVAX), Bristol Myers Squibb (BMY), Rexahn Pharmaceuticals (REXN) and ImmunoGen (IMGN).

Company Calendar

Last Earnings
11/13/2017
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:OREX
CIK
1382911
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:OREX) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners